Sipagladenant (Compound I) is an orally active inverse agonist targeting the adenosine receptor A2A [1]. It possesses potential for utilization in research pertaining to frontal lobe dysfunction [2].
Selexipag Active Metabolite-D7是Selexipag Active Metabolite (T3S2007)的氘代化合物。Selexipag Active Metabolite的CAS号为475085-57-5。MRE269是一种口服的长效前列环素受体激动剂前药,是Selexipag 的活性代谢物,用于治疗肺动脉高压。